Much-Touted Remdesivir Fails To Reduce COVID-19 Deaths; Results Of WHO-Coordinated Solidarity Trial 16/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin Two more experimental COVID-19 drugs, including the much-touted Remdesivir, appear to have fallen by the wayside, failing to show significant reductions in mortality among seriously ill patients. Interim results on Remdesivir and three other drug treatments being studied as part of the WHO Solidarity Therapeutics Trial, the world’s largest randomized controlled trial of COVID-19 drugs, […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Mobilization For And In Africa Is Certainly Insufficient – Says Geneva Health Forum’s Eric Comte 06/05/2020 Kyra Dupont/Geneva Solutions From a small and modest gathering of booths and stands in 2006, the Geneva Health Forum has grown into an international event with a strong array of scientific sessions. Although the GHF was forced to postpone its eighth annual conference, from March to 16-18 November due to the COVID-19 pandemic, that has not prevented the […] Continue reading -> Posts navigation Newer posts
China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Mobilization For And In Africa Is Certainly Insufficient – Says Geneva Health Forum’s Eric Comte 06/05/2020 Kyra Dupont/Geneva Solutions From a small and modest gathering of booths and stands in 2006, the Geneva Health Forum has grown into an international event with a strong array of scientific sessions. Although the GHF was forced to postpone its eighth annual conference, from March to 16-18 November due to the COVID-19 pandemic, that has not prevented the […] Continue reading -> Posts navigation Newer posts
First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Mobilization For And In Africa Is Certainly Insufficient – Says Geneva Health Forum’s Eric Comte 06/05/2020 Kyra Dupont/Geneva Solutions From a small and modest gathering of booths and stands in 2006, the Geneva Health Forum has grown into an international event with a strong array of scientific sessions. Although the GHF was forced to postpone its eighth annual conference, from March to 16-18 November due to the COVID-19 pandemic, that has not prevented the […] Continue reading -> Posts navigation Newer posts
Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Mobilization For And In Africa Is Certainly Insufficient – Says Geneva Health Forum’s Eric Comte 06/05/2020 Kyra Dupont/Geneva Solutions From a small and modest gathering of booths and stands in 2006, the Geneva Health Forum has grown into an international event with a strong array of scientific sessions. Although the GHF was forced to postpone its eighth annual conference, from March to 16-18 November due to the COVID-19 pandemic, that has not prevented the […] Continue reading -> Posts navigation Newer posts
Mobilization For And In Africa Is Certainly Insufficient – Says Geneva Health Forum’s Eric Comte 06/05/2020 Kyra Dupont/Geneva Solutions From a small and modest gathering of booths and stands in 2006, the Geneva Health Forum has grown into an international event with a strong array of scientific sessions. Although the GHF was forced to postpone its eighth annual conference, from March to 16-18 November due to the COVID-19 pandemic, that has not prevented the […] Continue reading -> Posts navigation Newer posts